• NSAIDs Deracoxib and Piroxicam: In Vitro Effects on Canine O

  2026-06-15

  This study evaluates the cytotoxic effects of deracoxib and piroxicam on canine osteosarcoma cell viability in vitro, revealing that deracoxib is more potent than piroxicam at inhibiting tumor cell growth without affecting fibroblasts. The findings indicate concentration-dependent cytotoxicity but no evidence of apoptosis under tested conditions, providing insight into the nuanced potential of NSAIDs in veterinary oncology.

• Nintedanib (BIBF 1120): Reliable Solutions for Cancer Assays

  2026-06-15

  This in-depth guide explores real laboratory scenarios where Nintedanib (BIBF 1120), SKU A8252, delivers reproducible, quantitative outcomes in cell viability and apoptosis assays. Drawing on peer-reviewed evidence and validated protocols, it highlights practical advantages for biomedical researchers seeking robust antiangiogenic agent workflows.

• HotStart™ 2X Green qPCR Master Mix: Precision in RNA Biomark

  2026-06-14

  Explore how HotStart™ 2X Green qPCR Master Mix advances SYBR Green qPCR master mix applications in RNA biomarker discovery and complex gene expression studies. This article uniquely bridges mechanistic innovation with assay design, delivering expert guidance for translational research.

• (+)-Bicuculline: Technical Guidance for GABAA Antagonism Wor

  2026-06-13

  (+)-Bicuculline is a classical GABAA receptor antagonist used to dissect GABAergic signaling and synaptic NMDA receptor modulation in neuroscience research. It is not suitable for diagnostic or therapeutic applications, and robust experimental outcomes depend on precise solubility management and workflow adherence. This guide distills actionable parameters and troubleshooting for optimal laboratory use.

• GLP-1 (9-36) Amide: Unveiling Antagonist Complexity in Metab

  2026-06-12

  Explore the advanced roles of GLP-1 (9-36) amide as a glucagon-like peptide-1 receptor antagonist in metabolic and diabetes research. This article reveals unique mechanistic insights and practical assay implications beyond existing guides.

• IL-1β Tetrapeptide Sequence Regulates Inflammatory Caspase A

  2026-06-12

  This study reveals that the P4-P1 tetrapeptide sequence of IL-1β is a key determinant for its selective recruitment and activation by inflammatory caspases, influencing the generation of bioactive cytokine species. These mechanistic insights refine our understanding of inflammasome signaling and have practical implications for disease models targeting IL-1β and IL-18 processing.

• Recombinant Human Oncostatin M: Mechanisms & Research Use

  2026-06-11

  Recombinant Human Oncostatin M (rh-Oncostatin M) is a biologically active, tag-free cytokine used for cell proliferation and cytokine induction studies. This product, produced in E.coli and lyophilized for stability, provides high purity and reproducibility in research models. Its precise activity profile enables robust, evidence-backed workflow integration.

• Trichostatin A (TSA): Protocols for Epigenetic and Cancer Re

  2026-06-11

  Trichostatin A (TSA) is a well-characterized HDAC inhibitor used to study epigenetic regulation, cancer cell proliferation, and cell cycle control. Researchers rely on TSA for precise, reproducible modulation of histone acetylation in cell and animal models. TSA is not recommended for use in workflows requiring aqueous solubility or extended solution stability.

• Isoprinosine: Mechanisms and Evidence for Antiviral Immunoth

  2026-06-10

  Isoprinosine (inosine pranobex) is a multi-component immunomodulatory agent with proven efficacy against acute respiratory viral infections and inhibition of HHV-1 replication. Its mechanism involves direct antiviral effects as well as enhancement of immune cell responses, with performance validated in vivo and in clinical trials. This article clarifies molecular mechanisms, use-case boundaries, and protocol parameters for research and clinical applications.

• Poly(I:C): Beyond TLR3 Agonism—New Frontiers in Immune Modul

  2026-06-10

  Explore Poly(I:C), a synthetic double-stranded RNA analog, as more than a TLR3 agonist—delve into its unique role in neuroimmune regulation, assay design, and advanced immunology research, with practical insights for experimental optimization.

• Baicalin Methyl Ester: Mechanistic Precision in Gut Barrier

  2026-06-09

  This article explores how baicalin methyl ester, a leading esterified derivative of baicalin, is redefining the mechanistic landscape of LPS-induced intestinal barrier damage research. Integrating rigorous experimental evidence, competitive positioning, and translational strategy, it provides researchers with actionable guidance and future-facing insights, while highlighting APExBIO’s BME as a foundational tool.

• Pterostilbene Enhances Mitophagy to Delay Fibroblast Senesce

  2026-06-09

  Zhou et al. (2025) demonstrate that pterostilbene delays senescence in human dermal fibroblasts by promoting mitochondrial quality control through enhanced mitophagy. These findings clarify the cellular mechanisms of dermal aging and provide a robust platform for anti-aging research targeting mitochondrial function.

• EdU Imaging Kits (HF488): Elevating Quantitative Cell Prolif

  2026-06-08

  Unlock advanced cell proliferation analysis with EdU Imaging Kits (HF488), leveraging 5-ethynyl-2'-deoxyuridine and click chemistry for precise DNA synthesis measurement. This article uniquely explores how assay sensitivity, workflow optimization, and multi-omics integration drive modern biomarker and therapeutic discovery.

• Prestained Protein Marker (Triple color, EDTA free, 10-250 k

  2026-06-08

  The Prestained Protein Marker (Triple color, EDTA free, 10-250 kDa) addresses the need for reliable, visually distinct molecular weight standards in SDS-PAGE and Western blot assays, especially where EDTA-free formulation and compatibility with fluorescent imaging or phosphoprotein analysis are critical. It should not be used for direct protein quantification or substituted for unstained markers in precise migration studies.

• Hybridization and Pluripotency Network Rewiring in Xenopus l

  2026-06-07

  This study dissects how evolutionary hybridization in Xenopus laevis caused extensive rewiring of the pluripotency gene regulatory network. By integrating chromatin profiling and transcriptional analysis, the authors reveal asymmetric genome activation between subgenomes, highlighting both regulatory divergence and conservation of core gene dosage. These findings illuminate how polyploidy can reshape gene control in early vertebrate development.

16295 records 1/1087 page Next 12345 下5页 Last page